Case summary

Background (age, sex, occupation, baseline function)

  • 85-year-old female, retired office worker who lives alone
  • Usually manages at home with support from family for meals, shopping and housework

History of presentation/reason for review

  • Admitted to hospital after being found by family member on the bathroom floor having fallen overnight
  • Spiking temperatures, complaining of back pain, dysuria, urinary frequency and new urinary incontinence. Has signs and symptoms of heart failure including increasing shortness of breath and ankle swelling
  • Family say she is more confused than usual, resisting help to get into the ambulance, resisting offers of food and fluid
  • Single dose of gentamicin given empirically on the day of admission for a working diagnosis of upper urinary tract infection
    • After receiving the dose, she removed the intravenous cannula and resisted attempts to re-site the cannula, therefore oral treatment considered
  • MSU result showed multiple antibiotic resistance with sensitivity to amoxicillin and so treatment with oral penicillin was considered.
  • The nature of penicillin allergy was discussed with the individual and her family. According to GP records and next of kin penicillin “allergy” was nausea and diarrhoea more than 20 years ago during a course of amoxicillin for a chest infection. No reported rash or need for hospitalisation. At the time, she finished the course, and the GP documented the allergy

Current medical history and relevant co-morbidities

  • Heart failure with preserved ejection fraction (ECHO within the last year)
  • Mild Alzheimer’s dementia (MMSE 23/30) – 4 years ago
  • COPD – 12 years ago
  • Generalised osteoarthritis – 27 years ago

Current medication and drug allergies (include over the counter (OTC) preparation, traditional medicines and herbal remedies)

Allergies: Penicillin

Current medications:

  • Atorvastatin 80mg tablets: one tablet in the morning
  • Donepezil 5mg tablets: one tablet in the morning
  • Furosemide 20mg tablets: one tablet in the morning
  • Lisinopril 5mg tablets: one tablet in the morning
  • Macrogol 3350 sachets: one sachet twice daily
  • Paracetamol 500mg caplets: two caplets four times daily
  • Salbutamol 200 microgram dry powder inhaler: one inhalation when required for shortness of breath/ wheeze
  • Senna 7.5mg tablets: two tablets at night
  • Trelegy Ellipta® (fluticasone 92 micrograms/ vilanterol 22 micrograms/ umeclidinium 65 micrograms) dry powder inhaler, one inhalation in the morning

Over the counter medicines: nil

Lifestyle and current function

  • The family feel that medication is not being taken regularly, boxes of tablets and inhalers are often found around the house
  • Ex-smoker, 10 pack years, stopped 20 years ago
  • Alcohol occasionally at celebratory events
  • Walks for about a mile most days with a friend or family member
  • Clinical Frailty Score (Rockwood) 5 (living with mild frailty)

“What matters to me” (ideas, concerns and expectations of treatment)

  • She has always expressed a wish to maintain independence as long as possible. Currently has delirium
  • Family wish to support her at home for as long as possible with a focus for medication on symptom relief

Observations, examinations and results 

Note: local laboratory reference ranges may vary

  • Weight 47kg, Height 158cm, BMI 18kg/m2
  • BP 108/56 mmHg, pulse 68bpm regular, oxygen saturation 96% on air, respiration rate normal
  • Noted to have reduced mobility and marked pitting oedema to both knees
  • Urea and Electrolytes
    • Potassium 5.2mmol/L (3.5-5.3mmol/L)
    • Sodium 138mmol/L (133-146mmol/L)
    • Urea 8.6mmol/L (2.5-7.8mmol/L)
  • Creatinine 110micromol/L (60-120micromol/L), Calculated creatinine clearance 25 mL/min
  • WBC 9x109/L (4.0-10.0x109/L).
  • CRP 72mg/L (0-10mg/L)
  • ECG: sinus rhythm, heart rate 72bpm
  • Urine culture: sample sent by GP and results available the day after admission
    • Organism: Escherichia coli
    • Organism Growth 105 orgs/ml
    • Sensitive to amoxicillin, gentamicin, aztreonam
    • Resistant to trimethoprim, ciprofloxacin

Most recent relevant consultations

  • Recent dietetic advice provided regarding high nutrient density food to encourage weight gain and family have been incorporating that into meals
  • Whilst in hospital:
    • Lisinopril withheld on admission due to low blood pressure
    • Atorvastatin withheld on admission due to lack of indication
    • Furosemide continued due to oedema and increased shortness of breath
  • Furosemide continued due to oedema and increased shortness of breath

7 steps: Person specific issues to address

1.  Aims: What matters to the individual about their condition(s)?

Review diagnoses and consider:

  • Therapeutic objectives of drug therapy
  • Management of existing health problems
  • Prevention of future health issues, including lifestyle advice 

Ask person to complete PROMs (Questions to answer before medicines review) before their review

Person specific issues to address

  • She wishes to maintain independence as long as possible and return home as soon as able
  • Focus is on symptom relief - breathlessness, pain from osteoarthritis and maintaining cognition

 

2.  Need: Identify essential drug therapy

Identify essential drugs (not to be stopped without specialist advice)

  • Drugs that have essential replacement functions (e.g. levothyroxine) 
  • Drugs to prevent rapid symptomatic decline (e.g. drugs for Parkinson’s disease, heart failure) 

Person specific issues to address

  • As she has a UTI and delirium, antibiotic treatment is essential
  • Donepezil can delay progression to 24-hour care (priority for her)

 

3. Does the individual take unnecessary drug therapy?

Identify and review the continued need for drugs

  • what is medication for?
  • with temporary indications
  • with higher than usual maintenance doses
  • with limited benefit/evidence for use
  • with limited benefit in the person under review (see Drug efficacy & applicability (NNT) table)

Person specific issues to address

  • Review the continued need for IV antibiotics
  • Lisinopril of limited benefit as preserved ejection fraction so stop
  • She has had fewer than two exacerbations of COPD in the last year and no raised blood eosinophils - step down to LAMA/ LABA inhaler (Anoro Ellipta®)
  • Discuss need for laxatives: could be used when required

 

4.  Effectiveness: Are therapeutic objectives being achieved?

Identify the need for adding/intensifying drug therapy to achieve therapeutic objectives

  • to achieve symptom control
  • to achieve biochemical/clinical targets
  • to prevent disease progression/exacerbation
  • is there a more appropriate medication to achieve goals?

Person specific issues to address

  • Judged to be very low probability of immediate penicillin hypersensitivity reaction, and so after discussion with her and next of kin, proceeded to amoxicillin oral challenge
  • Given single dose of oral amoxicillin and monitored at 10, 20, 40 and 60 minutes. Experienced no symptoms of nausea, no rash or lip/tongue tingling or swelling, no tachycardia or hypotension
  • Proceeded to a course of amoxicillin for seven days for a suspected upper UTI. Antibiotics were completed without any adverse effect
  • Monitor breathlessness (also review inhalers)

 

5. Safety: Does the individual have or is at risk of ADR/ side effects? Does the patient know what to do if they’re ill?

Identify individual safety risks by checking for

Identify adverse drug effects by checking for

  • specific symptoms/laboratory markers (e.g. hypokalaemia)
  • cumulative adverse drug effects (see ADR table)
  • drugs used to treat side effects caused by other drugs

Medication Sick Day guidance

  • Ensure discussion and clear information on which medicines to withhold at times of dehydrating illness

Person specific issues to address

  • Medication Sick Day Guidance for furosemide and lisinopril
  • Donepezil caution in COPD but control is good
  • Paracetamol dose in individual weighing less than 50kg: reduce dose and consider adding ibuprofen gel for painful joints

 

6.  Sustainability: Is drug therapy cost-effective and environmentally sustainable?

Identify unnecessarily costly drug therapy by

  • considering more cost-effective alternatives, formulary choices, safety, convenience

Consider the environmental impact of

  • Inhaler use
  • Single use plastics
  • Medicines waste
    • over-ordering
    • disposal
  • Water pollution 

Person specific issues to address

  • Consider use of oral rather than IV antibiotic (e.g. individual acceptability and sustainability)  
  • After assessment by a pharmacy technician, she is struggling to use dry powder devices. She cannot “feel” the dose being taken and therefore orders more inhalers every month, presuming that it is empty. After discussion about how the dry powder device works, she felt more confident she was receiving the required dose.
  • Advised to dispose of medicines through the community pharmacy
  • Advised to only order what is needed, do not stockpile medicines  

 

7.  Person-centredness: Is the person willing and able to take drug therapy as intended?

Does the person understand the outcomes of the review?

  • Consider Teach back

Ensure drug therapy changes are tailored to individual’s preferences. Consider

  • is the medication in a form they can take?
  • is the dosing schedule convenient?
  • what assistance is needed?
  • are they able to take medicines as intended?

Agree and communicate plan

  • discuss and agree with the individual/carer/welfare proxy therapeutic objectives and treatment priorities
  • include lifestyle and holistic management goals
  • inform relevant health and social care providers of changes in treatments across the transitions of care

Ask person to complete PROMs (Questions to answer after medicines review) after their review

Agreed plan

  • On discharge the GP was informed that the penicillin allergy was de-labelled and her GP records were updated and discussed with family so that they were aware for future episodes
  • Stop Clear note on discharge to GP about reason for this
  • Reduce paracetamol dose to 500mg up to four times a day
  • Change Trelegy® to Anoro Ellipta® device
  • Referred to the GP practice pharmacy technician to assess ways of supporting medicines management at home and remove unnecessary medicines
  • Ensure a written copy of the plan made for future reference by individual, family and carers

 

Key concepts in this case

  • Penicillin challenge can only be undertaken if there is a clear documented assessment of risk.273
  • There must be careful assessment of the nature of the “allergy” which includes associated symptoms and the timing of the reaction. Explain the purpose of the penicillin challenge to the person. Following successful oral challenge, it is essential to communicate the implications to the individual and family, and to the GP for the allergy label to be removed from medical records
  • Penicillin challenge would ideally be done on an elective basis, through an allergy clinic or similar setting. However, at present such clinics are not available in every area. In practice it may be appropriate to undertake penicillin challenge opportunistically in an acute setting for an individual who is clinically stable273
  • Do not use dipstick to diagnose UTIs in individuals over 65 years. Dipsticks become more unreliable with increasing age over 65 years.
  • Advice on management of UTI in people over 65 is available341
  • Nitrofurantoin is not excreted in urine in renal impairment, and therefore a caution in use if eGFR<45ml/min. Short courses (three to seven days may be considered at eGFR 30- 44ml/min)342
  • For older women with low body weight, calculated creatinine clearance is often markedly reduced with only moderately increased serum creatinine
  • Inhaler choice and technique: dry powder inhaler (DPI) versus metered dose inhaler (MDI). Ensure the person understands the action (the lack of feeling of a dose being administered) of the DPI. MDI may be more helpful with a spacer/mask for some people, however there is a need to balance this against the environmental effect. The least sustainable drug is the one that is not taken
  • Inhaled corticosteroid withdrawal in COPD is possible where a person has fewer than two exacerbations per year and no raised eosinophils
  • Differentiating breathlessness from heart failure and COPD. The individual had not been taking furosemide regularly prior to admission and oedema and breathlessness improved when this was taken in hospital